H.RES.403: Providing for consideration of the bill (H.R. 1629) to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes; providing for consideration of the resolution (H.

On agreeing to the resolution Agreed to by the Yeas and Nays: 212 - 206 (Roll no. 147).

On ordering the previous question Agreed to by the Yeas and Nays: 217 - 209 (Roll no. 146).

Considered as unfinished business.

Considered as privileged matter.

Motion to reconsider laid on the table Agreed to without objection.

POSTPONED PROCEEDINGS - At the conclusion of debate on H.Res. 403, the Chair put the question on ordering the previous question and by voice vote, announced that the ayes had prevailed. Mrs. Fischbach demanded the yeas and nays and the Chair postponed further proceedings until later in the legislative day.

DEBATE - The House proceeded with one hour of debate on H. Res. 403.

On agreeing to the resolution Agreed to by the Yeas and Nays: 212 - 206 (Roll no. 147). (text: CR H2473)

On ordering the previous question Agreed to by the Yeas and Nays: 217 - 209 (Roll no. 146). (consideration: CR H2480)

Considered as unfinished business. (consideration: CR H2480-2481)

Considered as privileged matter. (consideration: CR H2473-2479)

Placed on the House Calendar, Calendar No. 17.

The resolution provides for consideration of H.R. 1629 under a closed rule and H. Res. 275 under a closed rule. The resolution provides for one hour of debate on both the bill and resolution. The rule provides that H. Res. 398 is hereby adopted. The rule provides at any time through the legislative day of Thursday, May 20, 2021, the Speaker may entertain motions offered by the Majority Leader or designee with respect to multiple measures that were object of motions to suspend the rules on the legislative days of May 17 or 18, 2021.

The House Committee on Rules reported an original measure, H. Rept. 117-37, by Ms. Scanlon.